Linde Earnings Tomorrow With Options Skewed and Shorts Rebuilding

Linde reports Q3 results tomorrow, October 29, with a put/call ratio running above its recent norm and short interest quietly climbing over the past month, a setup worth watching given the stock has fallen sharply after each of its last two prints.

Options positioning is the clearest signal of caution ahead of the release. The put/call ratio is 1.42, above its 20-day average of 1.37 and near the upper end of the past year's range, with the 52-week high at 1.51. The z-score of 1.09 is not extreme, but the ratio has held persistently elevated all week, suggesting a steady bid for downside protection rather than a single day's spike.

Short interest has climbed 23% over the past month to 1.33% of the free float, a level that is still low in absolute terms. Borrow is easy: availability is effectively unlimited, and the cost to borrow has edged up to 0.52% from around 0.44% a week ago, still negligibly cheap. Short sellers are not crowding in, but the month-on-month rebuild is a change of direction worth noting alongside the options skew.

The Street remains constructive, but has been trimming targets. Recent analyst moves have all been in one direction. Citigroup cut its target to $560, UBS to $574, and RBC Capital to $549, each maintaining a positive rating. Barclays initiated with an Overweight at $577 in mid-October, a partial offset. The consensus target of $545 implies roughly 7% upside from the current $508.65. The stock's trailing P/E is 26.4 and EV/EBITDA is 17.2, with the P/E up more than 1.7 points over the past 30 days as the stock has rallied 8%. The dividend score ranks in the 97th percentile of Linde's universe, reflecting the company's consistent payout track record.

The two most recent earnings days are the sharpest piece of context for tomorrow. Linde dropped 5.5% on the day of its Q2 2026 print and a further 3.7% over the following five sessions. The Q1 2026 print produced a 6.4% single-day fall, with a 4.1% decline over the subsequent week. Both moves came despite analysts maintaining positive ratings through each episode, which is the core tension: the Street has consistently held its Buy and Outperform calls, yet the stock has sold off on each release. The bull case rests on manufacturing volume growth of 4% year-on-year and strength in Asia-Pacific electronics, where operating profit rose 8% and margins reached 29%. The bear case points to a 1% slide in healthcare revenues, softness in U.S. home care, and the vulnerability of merchant gas volumes to any further demand deterioration.

APD and ECL, the two closest correlated peers, both moved slightly higher over the past week, up 1.5% and 1.1% respectively. Linde's 1.3% gain modestly outpaced both. Retail attention on Linde is running at a z-score of 2.17 against its own 90-day history, the highest it has been in some time, consistent with investors revisiting the name ahead of tomorrow's report.

The specific thing to watch is what the Q3 print says about healthcare volumes and Asia-Pacific project momentum. Those two lines have pulled in opposite directions for two quarters running, and how management guides on both will determine whether tomorrow extends the pattern of post-earnings selling or breaks it.